Evidence map›Paper›PMID 36205548›Full record

ArticlePharmaceutical biology2022

Ming Dong Si, Meng Wu, Xi Zhen Cheng, Zhi Hong Ma, Yu Guang Zheng, Jing Li, Si Li, Yong Xing Song, Donglai Ma

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Nutrients · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ming Dong SiSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Meng WuSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Xi Zhen ChengSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Zhi Hong MaSchool of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.ORCID 0000-0001-9989-9578
Yu Guang ZhengSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Jing LiSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Si LiSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Yong Xing SongSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Donglai MaSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
Hebei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

context

objectiveThis study explored the therapeutic effects and mechanism of MATERIALS AND

methodsAfter a week of adaptive feeding, 32 Sprague-Dawley rats were divided into four groups: (1) Control, (2) Control-S, (3) Model, and (4) Model-S. During the 12 experimental weeks, we established the Model using a high-fat diet. Control-S and Model-S were given 1.0 g/kg

resultsWhen compared with Model rats, the DISCUSSION AND

conclusionsOur findings indicate that

Indexed as

Non-alcoholic Fatty Liver DiseaseSwertiaAlanine TransaminaseAlbuminsAlkaline PhosphataseAnimalsAspartate AminotransferasesCholesterolDiet, High-FatGlucoseInterleukin-6Lipoproteins, HDLLipoproteins, LDLLiverMyeloid Differentiation Factor 88NF-kappa BAlanine TransaminaseAlbuminsAlkaline PhosphataseAspartate AminotransferasesCholesterolGlucoseInterleukin-6Lipoproteins, HDLLipoproteins, LDLMyd88 protein, ratMyeloid Differentiation Factor 88NF-kappa BTlr4 protein, ratToll-Like Receptor 4TriglyceridesTumor Necrosis Factor-alphaWaterHyperlipidaemiainflammationlipid accumulation

Identifiers

PMID36205548
PMCPMC9559049
OpenAlexW4303433008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.